Digital Therapeutics For Fibromyalgia Market Forecast Highlights Expansion From $1.43 Billion To $3.06 Billion Through 2030
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Digital Therapeutics For Fibromyalgia Market Expansion Outlook: What Revenue Opportunities Lie Ahead?
The market for digital therapeutics targeting fibromyalgia has experienced a remarkable surge in recent times. Valued at $1.19 billion in 2025, it is projected to climb to $1.44 billion in 2026, reflecting a compound annual growth rate (CAGR) of 21.1%. This historical expansion has been driven by a heightened understanding of fibromyalgia management requirements, an increasing embrace of digital healthcare tools, the widespread use of smartphones in medical contexts, a broadening of telehealth offerings, and the recognized shortcomings of conventional pain management strategies.
Over the coming years, the digital therapeutics market targeting fibromyalgia is projected to experience explosive growth. By 2030, it is anticipated to climb to $3.07 billion, reflecting a compound annual growth rate (CAGR) of 20.8%. This forecast period’s expansion is fueled by a rising need for customized chronic pain management solutions, increased incorporation of artificial intelligence into therapy fine-tuning, broader adoption of reimbursement models for remote care, a heightened emphasis on treatment personalization driven by data, and growing partnerships between clinicians and digital health organizations. Key developments expected during this timeframe include a greater reliance on mobile therapies that track symptoms, the broader implementation of individualized digital care strategies, increased integration of wearable technology with treatment platforms, the growth of remote patient monitoring initiatives, and a stronger commitment to boosting patient involvement and treatment adherence.
Download A Free Sample Report For Comprehensive Market Insights:
Digital Therapeutics For Fibromyalgia Market Expansion Supported By Key Demand Factors
The anticipated expansion of the digital therapeutics market for fibromyalgia is being fueled by a rising consciousness of digital health solutions. These solutions comprise software-enabled tools and services—including patient applications, patient portals, and virtual-care platforms—that provide information, monitoring, and therapy via digital channels. This heightened awareness stems from government-supported initiatives and the widespread adoption of official health apps, which normalize online access to medical care. Digital therapeutics for fibromyalgia capitalize on this trend by engaging patients within those familiar digital environments, simplifying the onboarding process and improving adherence to app-based cognitive behavioral therapy, pacing exercises, and sleep programs, all while allowing for clinician supervision. For example, in December 2023, the National Health Service, a UK government department, reported that digital health app users reached 33.6 million, a rise from 16.8 million in 2022, and monthly logins increased by 54%, from 16.8 million to 25.8 million. Consequently, the growing awareness of digital health solutions is propelling the digital therapeutics for fibromyalgia market forward.
Digital Therapeutics For Fibromyalgia Market Segment Landscape: Which Areas Lead Market Development?
The digital therapeutics for fibromyalgia market covered in this report is segmented –
1) By Product Type: Software Applications, Devices, Platforms
2) By Therapy Area: Cognitive Behavioral Therapy, Mindfulness-Based Interventions, Pain Management, Other Therapy Types
3) By Distribution Channel: Online, Offline
4) By Application: Chronic Pain Management, Sleep Disorders, Fatigue Management, Other Applications
5) By End-User: Hospitals, Clinics, Homecare, Other End-Users
Subsegments:
1) By Software Applications: Mobile Applications, Web-Based Applications, Cloud-Based Applications, Virtual Reality Applications
2) By Devices: Wearable Devices, Handheld Devices, Smart Monitoring Devices, Connected Therapeutics Devices
3) By Platforms: Telehealth Platforms, Remote Monitoring Platforms, Patient Engagement Platforms, Data Analytics Platforms
Digital Therapeutics For Fibromyalgia Market Growth Trends Influencing Competitive Dynamics
Leading firms in the digital therapeutics market for fibromyalgia are advancing their technology by incorporating computerized behavioral therapy solutions, designed to provide scientifically backed interventions that enhance pain control, lessen fatigue, boost sleep quality, and bolster mental well-being, all through scalable, patient-focused digital tools. A computerized behavioral therapy device is a software-driven digital platform or application that enables remote delivery of structured, evidence-based cognitive or behavioral therapy interventions to patients, typically employing interactive modules, exercises, and instant feedback to address fibromyalgia symptoms and similar conditions. As an example, in May 2023, Swing Therapeutics, Inc., a biopharmaceutical company based in the United States, unveiled Stanza after obtaining U.S. FDA De Novo marketing clearance (DEN220083). This offering provides a 12-week, self-directed acceptance and commitment therapy (ACT) program tailored for fibromyalgia, with its effectiveness validated by a randomized controlled trial published in The Lancet, which reported notable clinical improvements. Accessible through smartphones on iOS or Android platforms, it engages users within the application to provide seamless, on-the-go therapy support.
Digital Therapeutics For Fibromyalgia Market Industry Leaders And Market Competition
Major companies operating in the digital therapeutics for fibromyalgia market are Grünenthal GmbH, Hinge Health Inc., DarioHealth Corp., Kaia Health, CogniFit Inc., Big Health Ltd., Remedee Labs, HelloBetter GmbH, AppliedVR Inc., PainDrainer, Swing Therapeutics Inc., Fern Health Inc., JOGO Health Inc., LIN Health Inc., MoreGoodDays, Happify Health Inc., Click Therapeutics Inc., Wellthy Therapeutics Pvt. Ltd., FlexifyMe, SleepioRx
Access The Complete Digital Therapeutics For Fibromyalgia Market Report:
Digital Therapeutics For Fibromyalgia Market Geographic Analysis: Where Is Demand Growing The Fastest?
North America was the largest region in the digital therapeutics for fibromyalgia market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital therapeutics for fibromyalgia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
